Population-Based Study Reveals New Risk-Stratification Biomarker Panel for Barrett's Esophagus-Reference-Cited by-同舟云学术

Population-Based Study Reveals New Risk-Stratification Biomarker Panel for Barrett's Esophagus

Published:2012-10 Issue:4 Volume:143 Page:927-935.e3
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Bird–Lieberman Elizabeth L.,Dunn Jason M.,Coleman Helen G.,Lao–Sirieix Pierre,Oukrif Dahmane,Moore Christina E.,Varghese Sibu,Johnston Brian T.,Arthur Kenneth,McManus Damian T.,Novelli Marco R.,O'Donovan Maria,Cardwell Christopher R.,Lovat Laurence B.,Murray Liam J.,Fitzgerald Rebecca C.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference46 articles.

1. Acceptability and accuracy of a non-endoscopic screening test for Barrett's oesophagus in primary care: cohort study;Kadri;BMJ,2010

2. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial;Lancet,2002

3. The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis;Desai;Gut,2012

4. Incidence of adenocarcinoma among patients with Barrett's esophagus;Hvid-Jensen;N Engl J Med,2011

5. Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study;Bhat;J Natl Cancer Inst,2011

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Narrowing the Discrepancy in Interobserver Variability With Barrett’s Esophagus With Low-Grade Dysplasia: Will Biomarkers or Risk Testing Help?;Foregut: The Journal of the American Foregut Society;2024-05-21

2. Molecular biomarkers of progression from Barrett’s esophagus to esophageal adenocarcinoma;Frontiers in Gastroenterology;2023-05-25

3. Surveillance in Barrett’s Esophagus: Challenges, Progress, and Possibilities;Gastroenterology;2023-04

4. The Future of Strategies to Reduce Mortality From Esophageal Adenocarcinoma;Foregut: The Journal of the American Foregut Society;2023-03

5. Defining an abnormal p53 immunohistochemical stain in Barrett's oesophagus‐related dysplasia: a single‐positive crypt is a sensitive and specific marker of dysplasia;Histopathology;2023-01-16